CureVac starts trial of experimental coronavirus vaccine, eyes launch next year
Unlisted German biotech firm CureVac will become the second company after rival BioNTech to launch human trials of an experimental coronavirus vaccine in the country, eyeing a potential approval in mid-2021. [Source]
Publication Date:Origin: reuters.com
Category: healthNews
Topics: launch, vaccine, coronavirus, experimental, CureVac, mid-2021, approval, potential, eyeing, country, trials, human, BioNTech, rival, company, second, become, biotech, German, Unlisted, trial, starts